Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 9, 2005
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
Show full opinionHide full opinion
Hemosol (HML-T)
August 9, 2005
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
DON'T BUY
DON'T BUY
June 13, 2005
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
Show full opinionHide full opinion
Hemosol (HML-T)
June 13, 2005
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
VAGUE
VAGUE
February 9, 2004
Speculative future.
Show full opinionHide full opinion
Hemosol (HML-T)
February 9, 2004
Speculative future.
BUY
BUY
January 28, 2004
It will expire again, company has run out of money many times. Take money out, while money is on the table.
Show full opinionHide full opinion
Hemosol (HML-T)
January 28, 2004
It will expire again, company has run out of money many times. Take money out, while money is on the table.
SELL
SELL
January 26, 2004
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
Show full opinionHide full opinion
Hemosol (HML-T)
January 26, 2004
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
DON'T BUY
DON'T BUY
December 15, 2003
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
Show full opinionHide full opinion
Hemosol (HML-T)
December 15, 2003
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
DON'T BUY
DON'T BUY
December 8, 2003
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
Show full opinionHide full opinion
Hemosol (HML-T)
December 8, 2003
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
DON'T BUY
DON'T BUY
December 8, 2003
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
Show full opinionHide full opinion
Hemosol (HML-T)
December 8, 2003
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
DON'T BUY
DON'T BUY
September 5, 2003
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
Show full opinionHide full opinion
Hemosol (HML-T)
September 5, 2003
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
DON'T BUY
DON'T BUY
March 31, 2003
Very speculative. FDA trials didn't go well.
Show full opinionHide full opinion
Hemosol (HML-T)
March 31, 2003
Very speculative. FDA trials didn't go well.
DON'T BUY
DON'T BUY
March 17, 2003
A lot of problems. May not survive.
Show full opinionHide full opinion
Hemosol (HML-T)
March 17, 2003
A lot of problems. May not survive.
DON'T BUY
DON'T BUY
January 14, 2003
A long way from being a mature company with mature products. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
January 14, 2003
A long way from being a mature company with mature products. Speculative.
DON'T BUY
DON'T BUY
January 14, 2003
Never seems to get it together.
Show full opinionHide full opinion
Hemosol (HML-T)
January 14, 2003
Never seems to get it together.
DON'T BUY
DON'T BUY
December 5, 2002
Worst is behind them. Would prefer owning through MDS.
Show full opinionHide full opinion
Hemosol (HML-T)
December 5, 2002
Worst is behind them. Would prefer owning through MDS.
WEAK BUY
WEAK BUY
November 7, 2002
OK for a long term hold. Buy on weakness.
Show full opinionHide full opinion
Hemosol (HML-T)
November 7, 2002
OK for a long term hold. Buy on weakness.
Showing 1 to 15 of 78 entries